Long, Justin M.
10 papers on CoChatORCID 0000-0003-0769-604X
Most cited papers
- Verified
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 3,204
- Verified
Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model
Shi, Y., Manis, M., Long, J., Wang, K., Sullivan, P. M., Remolina Serrano, J., Hoyle, R., & Holtzman, D. M. (2019) · Journal of Experimental Medicine
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 448
- Verified
MicroRNA-153 Physiologically Inhibits Expression of Amyloid-β Precursor Protein in Cultured Human Fetal Brain Cells and Is Dysregulated in a Subset of Alzheimer Disease Patients
Long, J. M., Ray, B., & Lahiri, D. K. (2012) · Journal of Biological Chemistry
Alzheimer's disease research and treatmentsMicroRNA in disease regulation
Cited by 198
- Verified
MicroRNA-339-5p Down-regulates Protein Expression of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 (BACE1) in Human Primary Brain Cultures and Is Reduced in Brain Tissue Specimens of Alzheimer Disease Subjects
Long, J. M., Ray, B., & Lahiri, D. K. (2014) · Journal of Biological Chemistry
Alzheimer's disease research and treatmentsMicroRNA in disease regulation
Cited by 187
- Verified
Autism, Alzheimer disease, and fragile X
Sokol, D. K., Maloney, B., Long, J. M., Ray, B., & Lahiri, D. K. (2011) · Neurology
Genetics and Neurodevelopmental DisordersAlzheimer's disease research and treatments
Cited by 141
- Verified
Novel upregulation of amyloid-β precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5′-untranslated region: Implications in Alzheimer’s disease
Long, J. M., Maloney, B., Rogers, J. T., & Lahiri, D. K. (2019) · Molecular Psychiatry
Alzheimer's disease research and treatmentsMicroRNA in disease regulation
Cited by 141
- Verified
Regulation of astrocyte lipid metabolism and ApoE secretion by the microglial oxysterol, 25-hydroxycholesterol
Cashikar, A. G., Toral-Rios, D., Timm, D., Romero, J., Strickland, M., Long, J. M., Han, X., Holtzman, D. M., & Paul, S. M. (2023) · Journal of Lipid Research
Cholesterol and Lipid MetabolismNeuroinflammation and Neurodegeneration Mechanisms
Cited by 72
- Verified
Cholesterol 25-hydroxylase mediates neuroinflammation and neurodegeneration in a mouse model of tauopathy
Toral-Rios, D., Long, J. M., Ulrich, J. D., Yu, J., Strickland, M. R., Han, X., Holtzman, D. M., Cashikar, A. G., & Paul, S. M. (2024) · Journal of Experimental Medicine
Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments
Cited by 47
- Verified
Towards cascading genetic risk in Alzheimer’s disease
Altmann, A., Aksman, L. M., Oxtoby, N. P., Young, A. L., ADNI, Weiner, M., Aisen, P., Petersen, R., Weiner, M., Aisen, P., et al. (2024) · Brain
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 18
- Verified
Deep learning to quantify the pace of brain aging in relation to neurocognitive changes
Yin, C., Imms, P., Chowdhury, N. F., Chaudhari, N. N., Ping, H., Wang, H., Bogdan, P., Irimia, A., Initiative, T. A. D. N., Weiner, M., et al. (2025) · Proceedings of the National Academy of Sciences
Dementia and Cognitive Impairment ResearchAdvanced MRI Techniques and Applications
Cited by 18
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free